Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two‐years’ experience
Cytopathology,
Journal Year:
2023,
Volume and Issue:
35(1), P. 78 - 91
Published: Oct. 24, 2023
Fine
needle
aspiration
cytology
(FNAC)
combined
with
rapid
on-site
evaluation
(ROSE)
and
ancillary
techniques
is
an
accurate
diagnostic
tool
for
many
pathologies.
However,
in
some
cases,
it
may
not
be
sufficient
actionable
diagnoses
or
molecular
testing,
especially
cases
that
require
large
immunohistochemical
panels
which
histological
features
are
mandatory
the
diagnosis.
Core
biopsy
(CNB),
on
contrary,
provides
samples
suitable
all
studies.
CNB
often
performed
by
radiologists
clinicians
without
direct
participation
of
cytopathologists,
can
lead
to
missed
delayed
diagnoses.
This
study
reports
experience
combining
FNAC
one
setting
cytopathologists.
The
aim
was
evaluate
impact
efficiency
procedures.One
hundred
forty-two
procedures
same
over
a
period
2
years
were
analysed.
compared
integrated
subsequent
categorized
as
follows:
non-contributory,
inadequate
samples;
confirmed,
when
same;
improved,
diagnosis
consistent
further
specified
corresponding
entity;
allowed,
produced
could
reached
FNAC;
changed,
changed
previous
diagnosis.CNB
confirmed
40.1%
(n
=
57/142).
improved
47.2%
67/142).
allowed
2.1%
3/142).
non-contributory
8.4%
12/142).
positive
whole
procedure
51.4%
total
73/142).
resulted
91.5%
130/142).
A
complete
assessment
successfully
14.7%
21/142)
utilizing
either
material.The
use
improves
accuracy
both
procedures.
approach
exploits
advantages
each
procedure,
enhancing
final
Language: Английский
Parsonage–Turner Syndrome following COVID-19 Vaccination: A Systematic Review
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(3), P. 306 - 306
Published: March 14, 2024
Background:
Parsonage–Turner
syndrome
(PTS)
is
an
inflammatory
condition
of
the
brachial
plexus,
with
more
than
half
patients
presenting
a
trigger,
such
as
infection
or
vaccination.
Our
objective
was
to
synthesize
clinical
and
paraclinical
features,
therapeutic
responses,
outcomes
PTS
post-COVID-19
Methods:
We
systematically
reviewed
two
databases
(LitCOVID
WHO
database
on
COVID-19)
up
January
2024
following
published
protocol
(OSF
registries).
Results:
included
59
cases.
occurred
frequently
in
males
(61.1%
mRNA
group,
83.3%
viral
vector
group).
Patients
group
were
younger
(41.7%
between
41
50
years
vs.
38.9%
61
70
years).
Most
cases
had
sudden
pain
within
weeks.
Unilateral
present
94.4%
all
vector-vaccinated
Symptoms
(97.1%
92.3%,
respectively),
usually
followed
weeks
by
motor
deficits
(97.2%
94.1%,
amyotrophy
(30%
81.8%,
paresthesia
(50%
27.3%,
sensory
loss
(33.3%
38.5%,
respectively).
Viral
vaccine
recipients
nerve
involvement
outside
plexus.
Ancillary
investigations
revealed
CSF
albuminocytological
dissociation
100%,
respectively)
ipsilateral
axillary
lymphadenopathy.
Two
worsened
after
second
dose,
another
recurred
influenza
One
patient
well
tolerated
dose
vaccine,
but
symptoms
reemerged
another.
Conclusions:
Current
evidence
suggests
may
occur
COVID-19
types,
some
subgroup
differences.
Also,
might
recur
subsequent
similar
unrelated
vaccines.
Language: Английский
Pitfalls in Lymph Node Fine Needle Aspiration Cytology
Min En Nga
No information about this author
Acta Cytologica,
Journal Year:
2023,
Volume and Issue:
68(3), P. 260 - 280
Published: Dec. 20, 2023
Fine
needle
aspiration
cytology
(FNAC)
is
an
accurate,
minimally
invasive,
and
cost-effective
biopsy
method
for
enlarged
lymph
nodes.
While
the
role
of
node
FNAC
in
diagnosis
infectious
or
reactive
conditions
metastatic
malignancy
unquestioned,
differing
views
still
exist
on
its
lymphoma.
Nevertheless,
regardless
practice
setting,
pitfalls
potential
error
exist,
it
incumbent
upon
pathologist
to
be
aware
these
pitfalls,
as
this
first
line
defence
against
errors.
Language: Английский
Kikuchi Disease After SARS-CoV-2 Vaccination: A Case Report With Immunohistochemical Analyses
Yuichiro Hamamoto,
No information about this author
Michihiro Kawamura,
No information about this author
Hideo Mori
No information about this author
et al.
International Journal of Surgical Pathology,
Journal Year:
2023,
Volume and Issue:
32(6), P. 1123 - 1128
Published: Nov. 19, 2023
SARS-CoV-2
vaccines
have
been
administered
in
many
countries
after
the
COVID-19
pandemic.
Lymphadenopathy
is
a
side
effect
of
vaccine.
We
report
rare
example
Kikuchi
disease
cervical
lymph
nodes
vaccination.
A
41-year-old
man
complained
swollen
neck
and
fever
9
days
first
dose
mRNA-1273
Computed
tomography
revealed
enlarged
nodes.
Fine
needle
aspiration
resection
were
performed,
clinicopathological
diagnosis
was
consistent
with
disease.
Histologically,
resected
lost
their
polarity,
histiocytes
aggregated
karyorrhectic
nuclear
debris
apoptosis.
positive
cells
small
lymphocytes
detected
by
immunohistochemistry.
This
that
demonstrated
expression
post-SARS-CoV-2
Language: Английский
Peripheral lymphadenopathy of unknown origin in adults: a diagnostic approach emphasizing the malignancy hypothesis
Ivana Hanzalova,
No information about this author
Maurice Matter
No information about this author
Schweizerische medizinische Wochenschrift,
Journal Year:
2024,
Volume and Issue:
154(7), P. 3549 - 3549
Published: July 31, 2024
The
term
lymphadenopathy
refers
to
an
abnormality
in
size,
consistency
or
morphological
aspect
of
one
several
lymph
nodes.
Although
lymphadenopathies
are
commonly
observed
everyday
clinical
practice,
the
difficulty
differentiating
benign
and
malignant
disease
may
delay
therapeutic
approaches.
present
review
aims
update
diagnostic
algorithms
different
situations
based
on
currently
available
literature.
A
literature
was
performed
assess
current
knowledge
approach.
short
vignette
used
as
example
a
typical
presentation.
This
case
metastatic
with
incomplete
patient
history
demonstrates
how
misleading
such
be,
leading
delayed
diagnosis
even
fatal
outcome.
Any
persisting
for
more
than
2
weeks
should
be
considered
suspicious
deserves
further
investigation.
Precise
examination,
meticulous
history-taking
search
associated
symptomatology
still
cornerstones
diagnosing
origin
condition.
next
step
depends
anatomical
region
specific
patient’s
situation.
Imaging
starts
ultrasound,
while
computed
tomography
(CT)
magnetic
resonance
imaging
(MRI)
allow
assessment
surrounding
structures.
If
remains
uncertain,
tissue
sampling
histological
analyses
performed.
Except
head
neck
loco-regional
lymphadenopathy,
there
no
methodical
guidelines
persistent
lymphadenopathy.
clarifies
confusing
complex
situations.
accuracy
fine
needle
aspiration
cytology
could
increased
by
using
core
biopsy
immunocytologic
flow
cytometric
methods.
Notably,
except
area,
open
best
option
when
lymphoma
is
suspected
inconclusive
results
previous
obtained.
incidence
varies
its
location
various
strategies.
In
unknown
primary
origin,
European
Society
Medical
Oncology
(ESMO)
modern
methods
like
next-generation
sequencing
(NGS)
help
manage
cases.
Language: Английский
COVID-19 vaccine-associated lymphadenopathy: a review
Infezioni in Medicina,
Journal Year:
2024,
Volume and Issue:
32(2)
Published: May 30, 2024
Following
the
introduction
of
RNA-based
vaccines,
COVID-19
vaccine-associated
clinical
lymphadenopathy
(C19-LAP)
has
been
reported
as
a
side
effect.
Moreover,
subclinical
detected
on
imaging
(SLDI)
also
observed,
mainly
incidental
findings
while
performing
screening
tests
oncological
patients.
In
these
cases,
surgical
lymphadenectomy,
fine-needle
aspiration
cytology
(FNAC)
and
core
needle
biopsy
(CNB)
have
used
valuable
diagnostic
tool
for
SLDI
C19-LAP.
this
review
clinical,
histologic
cytologic
features
C19-LAP
investigated.
A
search
studies
that
histopathology
cytopathology
was
performed
PubMed
Google
Scholar,
11
January
2023.
Thirty-one
reports
were
retrieved
included
in
pooled
analysis.
total,
we
54
patients
with
median
age
47
years.
our
research,
excision,
CNB
and/or
FNAC
or
enlarged
lymph
nodes
cases.
Of
all
only
two
metastases
diagnosed
one
case
reactive
hyperplasia
atypical
follicles.
The
remaining
cases
(28
cases),
follicular
(13
Kikuchi-Fujimoto
disease
(6
granulomatous
lymphadenitis
(2
eosinophilic
node
abscesses
(1
case),
Langherans
cell
histiocytosis
Rosai-Dorfman
case).
represented
dilemma,
especially
oncologic
role
different
tools
discussed.
Language: Английский
Distinguishing Axillary Lymphadenopathy after COVID-19 Vaccination from Malignant Lymphadenopathy
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(12), P. 3387 - 3387
Published: June 9, 2024
Objectives:
To
study
the
differences
between
malignant
hypermetabolic
axillary
lymphadenopathy
(MHL)
and
COVID-19
vaccine-associated
(VAHL)
using
clinical
imaging.
Methods:
A
total
of
1096
patients
underwent
Positron
Emission
Tomography-Computed
Tomography
(PET-CT)
1
June
2021
30
April
2022
at
Ehime
University
Hospital.
In
total,
188
with
after
vaccination
were
evaluated.
The
classified
into
three
groups
such
as
VAHL
(n
=
27),
MHL
21),
equivocal
(EqHL;
n
140).
Differences
in
lymph
node
(LN)
swellings
statistically
analyzed
imaging
(echography,
CT,
18F-FDG
PET).
Results:
included
a
higher
female
population
(90.5%)
owing
to
frequency
breast
cancer
(80.9%).
Axillary
LNs
did
not
show
any
LN
fatty
hilums
(0%);
however,
those
EqHL
(15.8
36%,
respectively).
After
logistic
regression
analysis
who
had
without
hilums,
minor
axis
length
ellipticity
(minor
axis/major
axis)
largest
LN,
SUVmax,
Tissue-to-Background
Ratio
(TBR)
useful
distinguishing
lymphadenopathies.
receiver-operating
characteristic
(ROC)
indicated
that
cut-off
value
≥7.3
mm
for
(sensitivity:
0.714,
specificity:
0.684)
≥0.671
(0.667
0.773,
respectively)
highest
SUVmax
TBR
predictive
MHL.
Conclusions:
may
be
suspicious
malignancy,
even
have
received
vaccination.
Further
examinations,
PET,
are
recommended
patients.
Language: Английский